Skip to content

Author

Mercedes Serrano

We have 3 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

A deep network embedding and robust statistical framework for multi-omics integration in rare diseases: a case study in PMM2-CDG

Integrative analysis of multiomic datasets in rare diseases is often constrained by small-n cohorts, impeding the identification of robust and biologically meaningful disease mechanisms. We developed an end-to-end framework that combines multiomic integration, robust statistical inference and network representation lea...

Federico García-Criado, J. Córdoba-Caballero, Á. Esteban-Martos et al. · 0 citations
Clinical trial Open access Sep 2026

Results From a Phase 2, Open‐Label Study Evaluating the Safety, Tolerability, and Effect on Ataxia of GLM101 in Three Adult Patients With PMM2‐CDG

Phosphomannomutase 2 congenital disorder of glycosylation (PMM2‐CDG) is a rare, autosomal recessive disease caused by PMM2 deficiency, which impairs conversion of mannose‐6‐phosphate into mannose‐1‐phosphate (M1P) and disrupts N‐linked glycosylation. It typically results in a multisystem disorder in which a prominent c...

Mercedes Serrano, Florencia Epifani, Rose Marino et al. · 0 citations
Open access Aug 2026

Proteo‐Metabolomic Profiling of PMM2‐CDG Reveals Dysregulation of Retinoic Acid Synthesis, Myo‐Inositol, and the Hexosamine Pathway

Significant alterations in the retinoic acid synthesis pathway and hexosamine biosynthesis in PMM2‐CDG patient‐derived fibroblasts are identified and an association between intracellular myo‐inositol levels and disease severity is revealed.

Diana Gallego, G. Andreotti, M. Monticelli et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.